Breast Cancer

Breast Health

COVID-19

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Labor and Delivery

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Procedures

Sexual Dysfunction

Sexual Health

Sexually Transmitted Diseases

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Print Subscription

eNewsletter

Editorial Board

Partnerships

Articles

In a recent study, providers were more likely to recommend combined hormone replacement therapy (HRT) than estrogen-only HRT in patients with severe endometriosis because of recurrence risks from estrogen-only HRT.

Endometriosis recurrence from estrogen-only HRT

Patients are the biggest offenders, but many also encounter racism from colleagues and supervisors.

Nurses face widespread bias, study finds

In a recent study, nulliparous women with postpartum urinary incontinence recovered without intervention.

Intervention for postpartum urinary incontinence

In a recent study, the risks of neonatal low birth weight and perinatal depressive symptoms were greater in women who often or always felt unsafe in their neighborhood.

Impacts of perceived neighborhood safety on birth outcomes

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

LinkedIn

RSS Feed

Spotlight

Advances in the Management of Uterine Fibroids

CMV: In the Know

Expert Perspectives on Advances in Cervical Cancer Screening

NPWH

Supplement: Closing the Gap in Cervical Cancer Screening

Updates in the Pharmacotherapy of Endometriosis

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Authors

Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?

Advancements in Gynecological Oncology

Melissa Lind

Articles